KR20210036767A - Cosmetic composition with sea Lacto for antibacterial and antiinflammatory and manufacturing method thereof - Google Patents

Cosmetic composition with sea Lacto for antibacterial and antiinflammatory and manufacturing method thereof Download PDF

Info

Publication number
KR20210036767A
KR20210036767A KR1020190119202A KR20190119202A KR20210036767A KR 20210036767 A KR20210036767 A KR 20210036767A KR 1020190119202 A KR1020190119202 A KR 1020190119202A KR 20190119202 A KR20190119202 A KR 20190119202A KR 20210036767 A KR20210036767 A KR 20210036767A
Authority
KR
South Korea
Prior art keywords
parts
weight
extract
kelp
inflammatory
Prior art date
Application number
KR1020190119202A
Other languages
Korean (ko)
Inventor
오상태
Original Assignee
오상태
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 오상태 filed Critical 오상태
Priority to KR1020190119202A priority Critical patent/KR20210036767A/en
Publication of KR20210036767A publication Critical patent/KR20210036767A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9706Algae
    • A61K8/9711Phaeophycota or Phaeophyta [brown algae], e.g. Fucus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005Antimicrobial preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/85Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to an antibacterial anti-inflammatory sea lacto cosmetic composition, and a method for producing the same. The method comprises the steps of: (a) preparing processed Ecklonia cava extracts, Hizikia fusiforme extracts, kelp extracts, Pyropia yezoensis extracts, brown algae extracts, lactic acid bacteria, and oligosaccharide; (b) mixing 5-10 parts by weight of Hizikia fusiforme extracts, 20-35 parts by weight of kelp extracts, 5-8 parts by weight of Pyropia yezoensis extracts, 5-10 parts by weight of brown algae extracts, 30-90 parts by weight of lactic acid bacteria, and 3-25 parts by weight of oligosaccharide with respect to 100 parts by weight of Ecklonia cava extracts, and agitating the same for 30-45 minutes; (c) fermenting the same for 3-6 months at 30-43℃ and filtering the same to prepare a crude filtrate; and (d) preparing an antibacterial anti-inflammatory sea lactose cosmetic composition by adding 3-50 parts by weight of fucose with respect to 100 parts by weight of the crude filtrate, and stirring the same for 10-12 hours. By using natural ingredients and lactic acid bacteria derived from the sea, it is possible to mass-produce a feminine cleanser with excellent antibacterial and anti-inflammatory effects.

Description

항균 항염 씨락토 화장료 조성물 및 이의 제조방법 {Cosmetic composition with sea Lacto for antibacterial and antiinflammatory and manufacturing method thereof} [Cosmetic composition with sea Lacto for antibacterial and antiinflammatory and manufacturing method thereof]

본 발명은 항균 항염 씨락토 화장료 조성물 및 이의 제조방법에 관한 것이다.The present invention relates to an antibacterial anti-inflammatory sea lacto cosmetic composition and a method for producing the same.

대한민국 등록특허 제1962641호(등록일자: 2019.3.21., 발명의 명칭: 밤나무총포 추출물을 유효성분으로 함유하는 항균 및 항바이러스 활성을 가지는 조성물 및 이를 포함하는 여성청결제 조성물)는 밤나무총포 추출물을 유효성분으로 포함하되, 상기 항균 활성이 가드네렐라 바지날리스(Gardnerella vaginalis) 및 클라미디아 트라코마티스(Chlamydia trachomatis)에 대한 항균활성이고, 상기 항바이러스 활성이 인간 유두종바이러스(human papillomavirus, HPV)에에 대한 항바이러스 활성이고, 상기 밤나무총포 추출물이 항균 및 항바이러스 활성을 가지는 조성물 전체 중량에 대하여 0.0001 내지 10 중량%의 양으로 포함하여 항균 및 항바이러스 활성을 가지는 조성물을 유효성분으로 포함하는 여성청결제 조성물이 개시되어 있다.Republic of Korea Patent Registration No. 1962641 (Registration Date: March 31, 2019, Title of Invention: A composition having antibacterial and antiviral activity containing chestnut gunpox extract as an active ingredient, and a feminine cleansing composition containing the same) is effective in chestnut gunpox extract. Included as a component, wherein the antimicrobial activity is antibacterial activity against Gardnerella vaginalis and Chlamydia trachomatis, and the antiviral activity is against human papillomavirus (HPV). Disclosed is a feminine cleansing composition comprising a composition having antibacterial and antiviral activity as an active ingredient, including in an amount of 0.0001 to 10% by weight with respect to the total weight of the composition in which the chestnut musculus extract has antibacterial and antiviral activity. Has been.

이러한 종래 기술은, 밤나무총포 추출물을 포함하는 조성물이 여성 질염을 유발하는 가드네렐라 바지날리스에 대한 항균활성을 나타내며, 클라미디아 트라코마티스 감염을 억제하고 인간 유두종바이러스로부터 감염을 억제하여, 여성의 질로부터 감염되는 질병의 예방효능을 가진 조성물로서 유용하게 사용될 수 있고, 인체 점막에 대한 부작용이 거의 없으므로 안전하게 사용할 수 있다고 주장하는 반면, 제조 공정이 복잡한 단점이 있었다.In this prior art, the composition containing the chestnut musculus extract exhibits antimicrobial activity against Gardnerella vaginalis, which causes female vaginitis, inhibits Chlamydia trachomatis infection and inhibits infection from human papillomavirus, It can be usefully used as a composition having the effect of preventing diseases from infection from, and claims that it can be safely used because there are few side effects on the human mucosa, while the manufacturing process has a complex disadvantage.

상기와 같은 문제점을 해결하고자 창출된 본 발명의 목적은, 해양유래 천연 물질과 유산균을 이용한 항균 항염 씨락토 화장료 조성물 및 이의 제조방법을 제공하는 데 있다.An object of the present invention created to solve the above problems is to provide an anti-bacterial anti-inflammatory sea lacto cosmetic composition using marine-derived natural substances and lactic acid bacteria and a method for manufacturing the same.

이러한 본 발명의 목적은, (a) 가공된 감태추출물, 톳추출물, 다시마추출물, 방사무늬돌김추출물, 갈조추출물, 유산균 및 올리고당을 준비하는 단계와; (b) 감태추출물 100 중량부에 대하여, 톳추출물 5 ~ 10 중량부, 다시마추출물 20 ~ 35 중량부, 방사무늬돌김추출물 5 ~ 8 중량부, 갈조추출물 5 ~ 10 중량부, 유산균 30 ~ 90 중량부 및 올리고당 3 ~ 25 중량부를 혼합하여 30 ~ 45분간 교반하는 단계와; (c) 30 ~ 43℃에서 3 ~ 6개월 발효시킨 후 여과하여 초벌 여과물을 제조하는 단계와; (d) 상기 초벌 여과물 100 중량부에 대하여 푸코오스 3 ~ 50 중량부를 더 첨가한 후 10 ~ 12시간 교반하여 항균 항염 씨락토 화장료 조성물을 제조하는 단계로 이루어진 항균 항염 씨락토 화장료 조성물의 제조방법에 의해 달성될 수 있다.The object of the present invention is, (a) preparing a processed Ecklonia cava extract, a hetspberry extract, a kelp extract, a radiated patterned rock extract, a brown algae extract, a lactic acid bacterium and an oligosaccharide; (b) Based on 100 parts by weight of Ecklonia cava extract, 5 to 10 parts by weight of Totilla extract, 20 to 35 parts by weight of kelp extract, 5 to 8 parts by weight of radish-patterned seaweed extract, 5 to 10 parts by weight of brown algae extract, 30 to 90 parts by weight of lactic acid bacteria Mixing parts and 3 to 25 parts by weight of oligosaccharide and stirring for 30 to 45 minutes; (c) fermenting at 30 to 43° C. for 3 to 6 months and then filtering to prepare a crude filtrate; (d) a method for preparing an anti-bacterial anti-inflammatory shellacto cosmetic composition comprising the step of preparing an anti-bacterial anti-inflammatory shellacto cosmetic composition by adding 3 to 50 parts by weight of fucose to 100 parts by weight of the crude filtrate and stirring for 10 to 12 hours Can be achieved by

바람직하게는, 본 발명의 상기 (a)단계의 감태추출물은, 정제수 100 중량부에 대하여, 건조된 감태 30 ~ 45 중량부 및 산초씨유 0.1 ~ 0.3 중량부를 밀폐용기에 충전한 후 90 ~ 130℃에서 12 ~ 15시간 가열한 다음 여과하여 제조되고, 상기 (a)단계의 톳추출물은, 정제수 100 중량부에 대하여, 톳 분말 50 ~ 55 중량부, 자몽씨 추출물 0.1 ~ 0.1 중량부 및 올리브유 1 ~ 1.5 중량부를 밀폐용기에 충전한 후 90 ~ 130℃에서 12 ~ 15시간 가열한 다음 여과하여 제조되고, 상기 (a)단계의 다시마추출물은, (가) 건조된 다시마를 정제수에 5 ~ 10일간 침지한 후 10 ~ 15℃에서 재건조하는 단계와; (나) 재건조된 다시마를 자숙한 후 건조하는 공정을 1 ~ 5회 반복하는 단계와; (다) 자숙건조된 다시마를 분쇄하여 분말로 만드는 단계와; 정제수 100 중량부에 대하여, 다시마 분말 5 ~ 15 중량부를 혼합한 후 회전수 100 ~ 150rpm으로 30 ~ 35일간 교반한 후 여과한 다음 10 ~ 15℃에서 120 ~ 150일간 저장하여 제조되는 단계로 이루어지고, 상기 (a)단계의 방사무늬돌김추출물은, 정제수 100 중량부에 대하여, 방사무늬돌김 분말 30 ~ 35 중량부, 콩비지 분말 10 ~ 15 중량부 및 올리브유 1 ~ 1.5 중량부를 밀폐용기에 충전한 후 90 ~ 130℃에서 5 ~ 7시간 가열한 다음 여과하여 제조되는 것을 특징으로 한다.Preferably, the Ecklonia cava extract of the step (a) of the present invention is 90 to 130 parts by weight of dried Ecklonia cava and 0.1 to 0.3 parts by weight of dried Ecklonia cava based on 100 parts by weight of purified water. It is prepared by heating at °C for 12 to 15 hours and then filtering, and the extract of the hepatica extract of step (a) is 50 to 55 parts by weight of hemp powder, 0.1 to 0.1 parts by weight of grapefruit seed extract and olive oil 1 based on 100 parts by weight of purified water. Prepared by filling ~ 1.5 parts by weight in an airtight container, heating at 90 to 130°C for 12 to 15 hours, and then filtering. The kelp extract of step (a) is prepared by (a) dried kelp in purified water for 5 to 10 days. Re-drying at 10 to 15° C. after immersion; (B) repeating the process of drying the re-dried kelp after self-cooking 1 to 5 times; (C) pulverizing the self-dried kelp to form a powder; With respect to 100 parts by weight of purified water, 5 to 15 parts by weight of kelp powder is mixed, stirred for 30 to 35 days at a rotational speed of 100 to 150 rpm, filtered, and then stored at 10 to 15°C for 120 to 150 days. , After filling the radiated pattern protrusion extract of step (a) into an airtight container, 30 to 35 parts by weight of radioactive pattern protrusion powder, 10 to 15 parts by weight of soybean curd powder, and 1 to 1.5 parts by weight of olive oil based on 100 parts by weight of purified water It is characterized in that it is prepared by heating at 90 to 130°C for 5 to 7 hours and then filtering.

바람직하게는, 본 발명의 상기 (d)단계 이후에 상기 항균 항염 씨락토 화장료 조성물 100 중량부에 대하여 해초 발효추출물 1 ~ 50 중량부를 더 첨가하는 (e)단계를 더 포함하되, 상기 해초 발효추출물은, (ㄱ) 정제수 100 중량부에 대하여, 건조 세절된 감태 10 ~ 15 중량부, 건조 세절된 톳 5 ~ 7 중량부, 건조 세절된 다시마 5 ~ 10 중량부, 방사무늬돌김 5 ~ 10 중량부 및 세절 건조된 갈조 3 ~ 5 중량부를 혼합한 후 120 ~ 150℃에서 120 ~ 150분 가열한 후 30 ~ 35℃로 냉각한 다음 여과하여 여과액을 제조하는 단계와; (ㄴ) 상기 여과액 100 중량부에 대하여, 설탕 80 ~ 130 중량부 및 자몽씨 추출물 1 ~ 3 중량부를 밀폐용기에 충전한 후 30 ~ 35℃ 온도에서 3 ~ 5개월 발효한 후 여과하여 제조되는 단계로 이루어지는 것을 특징으로 한다.Preferably, after the step (d) of the present invention, further comprising a step (e) of further adding 1 to 50 parts by weight of seaweed fermentation extract based on 100 parts by weight of the antibacterial anti-inflammatory sealacto cosmetic composition, wherein the seaweed fermented extract Silver, (a) based on 100 parts by weight of purified water, 10 to 15 parts by weight of dry chopped Ecklonia cava, 5 to 7 parts by weight of dry chopped soybean paste, 5 to 10 parts by weight of dry chopped kelp, 5 to 10 parts by weight of spinneret And 3 to 5 parts by weight of finely dried brown algae, followed by heating at 120 to 150° C. for 120 to 150 minutes, cooling to 30 to 35° C., and filtering to prepare a filtrate; (B) Based on 100 parts by weight of the filtrate, 80 to 130 parts by weight of sugar and 1 to 3 parts by weight of grapefruit seed extract are filled in an airtight container, fermented at 30 to 35°C for 3 to 5 months, and then filtered. It characterized in that it consists of steps.

보다 바람직하게는, 상기 유산균은 락토바실러스 카제이, 락토바실러스 애시도필러스, 락토바실러스 불가리쿠스, 비피도박테리움 롱굼, 비피도박테리움 비피둠, 액티레귤라리스 또는 락토바실러스 람노서스 중 어느 하나 이상인 것을 특징으로 한다.More preferably, the lactic acid bacteria is one or more of Lactobacillus casei, Lactobacillus acidophilus, Lactobacillus bulgaricus, Bifidobacterium longum, Bifidobacterium bifidum, Actiregularis or Lactobacillus rhamnosus. It is characterized by that.

또한, 본 발명은 위의 방법들 중 어느 한 방법에 의해 제조된 항균 항염 씨락토 화장료 조성물에 의해 달성될 수 있다.In addition, the present invention can be achieved by the anti-bacterial anti-inflammatory siracto cosmetic composition prepared by any one of the above methods.

이상과 같은 본 발명은 해양 유래에 천연 재료 및 유산균을 이용하여 항균, 항염 효과가 우수하여 피부 트러블을 완화할 수 있는 화장료 조성물을 대량 제조할 수 있는 효과가 있다. 특히, 본 발명은 여아 및 여성이 함께 사용할 수 있을 정도로 사용상 안전성이 양호한 여성 청결제에 적용될 수 있는 장점이 있다.The present invention as described above has an effect of mass-producing a cosmetic composition capable of alleviating skin troubles with excellent antibacterial and anti-inflammatory effects using natural materials and lactic acid bacteria derived from the ocean. In particular, the present invention has an advantage that can be applied to a feminine cleaner with good safety in use so that girls and women can use it together.

이하, 본 발명의 실시예를 참조하여 설명하기로 한다.Hereinafter, it will be described with reference to an embodiment of the present invention.

1. 해초 추출물 제조하기1. Making seaweed extract

감태추출물 (Ecklonia cava extract) Ecklonia cava extract (Ecklonia cava extract)

고압수 또는 고압해수를 이용하여 감태의 이물질을 제거한 후 자연 건조한다.Use high-pressure water or high-pressure seawater to remove foreign substances from Ecklonia and dry naturally.

이후, 건조된 감태를 정제수에 30 ~ 120분간 침지한 다음 초음파 세척후 재건조한다. 여기서, 감태의 건조 및 초음파 세척은 해양 유래 천연물인 감태에 잔존하는 염분을 최대한 제거하기 위함이다.Thereafter, the dried Ecklonia cava is immersed in purified water for 30 to 120 minutes, and then re-dried after ultrasonic cleaning. Here, the drying and ultrasonic cleaning of Ecklonia cava is to remove the salt remaining in Ecklonia cava, a natural product derived from the ocean as much as possible.

계속해서, 정제수 100 중량부에 대하여, 건조된 감태 30 ~ 45 중량부 및 산초씨유 0.1 ~ 0.3 중량부를 밀폐용기에 충전한 후 90 ~ 130℃에서 12 ~ 15시간 가열한 다음 여과하여 준비한다. 여기서, 산초씨유는 통증완화, 항산화 및 항암효과가 있으며 추출물의 산패 및 감태의 잡내를 잡기 위하여 제공된 것이다.Subsequently, with respect to 100 parts by weight of purified water, 30 to 45 parts by weight of dried Ecklonia cava and 0.1 to 0.3 parts by weight of Sancho Seed oil are filled in an airtight container, heated at 90 to 130° C. for 12 to 15 hours, and filtered to prepare. Here, the sanchoseed oil has pain relief, antioxidant and anti-cancer effects, and is provided to capture rancidity of the extract and the odor of ecstasy.

일반적으로, 감태는 우리나라 제주도 일대 및 일부 남해안에 분포하는 다년생 식물로써 알긴산, 요오드 및 칼륨 등의 영양소가 많이 함유되어 있는 건강식품자원이다. 또한, 감태는 후코이단과 플로로탄닌 성분을 함유하고 있어 항산화효과, 항암효과, 항염효과, 노화억제효과 및 고혈압 억제효과 등이 있다.In general, Ecklonia cava is a perennial plant distributed in Jeju Island and some southern coasts of Korea, and is a health food resource containing a lot of nutrients such as alginic acid, iodine and potassium. In addition, Ecklonia cava contains fucoidan and fluorotannin components, so it has an antioxidant effect, an anticancer effect, an anti-inflammatory effect, an anti-aging effect, and an antihypertensive effect.

톳추출물 (Hizikia Fusiforme extract) Chop extract (Hizikia Fusiforme extract)

고압수 또는 고압해수를 이용하여 톳의 이물질을 제거한 후 자연 건조한다.Use high-pressure water or high-pressure seawater to remove foreign substances from Tot and then dry naturally.

이후, 건조된 톳을 압연 롤러를 통과시킨 후 분말로 만든다. 여기서, 건조된 톳을 압연후 분말로 만드는 이유는 후술되는 추출공정이 원활하게 구현되도록 하기 위함이다.Thereafter, the dried tot is passed through a rolling roller and then made into powder. Here, the reason why the dried tot is made into powder after rolling is to smoothly implement the extraction process described later.

계속해서, 정제수 100 중량부에 대하여, 톳 분말 50 ~ 55 중량부, 자몽씨 추출물 0.1 ~ 0.1 중량부 및 올리브유 1 ~ 1.5 중량부를 밀폐용기에 충전한 후 90 ~ 130℃에서 12 ~ 15시간 가열한 다음 여과하여 준비한다. 여기서, 자몽씨 추출물은 자연 방부제이고, 올리브유는 소포제이다.Subsequently, 50 to 55 parts by weight of hepatitis powder, 0.1 to 0.1 parts by weight of grapefruit seed extract, and 1 to 1.5 parts by weight of olive oil were filled in an airtight container and heated at 90 to 130°C for 12 to 15 hours, based on 100 parts by weight of purified water. Then prepare by filtering. Here, grapefruit seed extract is a natural preservative, and olive oil is an antifoam.

일반적으로, 톳은 우리나라 주문진 이남에서 서해안 장산곶까지 폭넓게 자생하는 다년생 해조류로써, 칼슘, 요오드, 철 등의 무기염류를 많이 함유하고 있어 혈관경화를 방지효과가 있으며 섬유질이 풍부하여 변비와 창자의 소화기능에 효과적인 건강식품자원이다.In general, tot is a perennial algae that grows widely from south of Jumunjin in Korea to Jangsangot on the west coast. It contains a lot of inorganic salts such as calcium, iodine, and iron, so it has the effect of preventing vascular sclerosis. It is rich in fiber, so it has constipation and digestive function of the intestines. It is an effective health food resource.

다시마추출물 (Laminaria Japonica extract) Seaweed extract (Laminaria Japonica extract)

고압수 또는 고압해수를 이용하여 다시마의 이물질을 제거한 후 건조한다.Use high-pressure water or high-pressure seawater to remove foreign substances from the kelp and dry.

이후, 건조된 다시마를 정제수에 5 ~ 10일간 침지한 후 10 ~ 15℃에서 자연건조하여 함수율이 3% 미만이 되도록 한다. 여기서, 건조된 다시마를 정제수에 침지하는 이유는 염분을 제거하기 위함이다.Thereafter, the dried kelp is immersed in purified water for 5 to 10 days and then naturally dried at 10 to 15°C so that the moisture content is less than 3%. Here, the reason why the dried kelp is immersed in purified water is to remove salt.

그런 다음, 건조된 다시마를 자숙한 후 건조하는 공정을 1 ~ 5회 반복한다. 여기서, 자숙 및 건조과정을 반복하는 이유는 다시마에 많이 함유된 후코이단의 농축하기 위한 것이다.Then, after the dried kelp is boiled, the process of drying is repeated 1 to 5 times. Here, the reason for repeating the self-cooking and drying process is to concentrate fucoidan contained in kelp.

계속해서, 건조된 다시마는 분쇄하여 분말로 만든다.Subsequently, the dried kelp is pulverized to form a powder.

마지막으로, 정제수 100 중량부에 대하여, 다시마 분말 5 ~ 15 중량부를 혼합한 후 회전수 100 ~ 150rpm으로 30 ~ 35일간 교반한 후 여과한 다음 10 ~ 15℃에서 120 ~ 150일간 저장하여 제조된다. 여기서, 정제수와 다시마 분말의 혼합물을 비가열 방법을 활용한 이유는 유효성분인 후코이단 및 라미닌이 파손되는 방지하기 위함이다.Finally, 5 to 15 parts by weight of kelp powder is mixed with respect to 100 parts by weight of purified water, and then stirred for 30 to 35 days at a rotational speed of 100 to 150 rpm, filtered, and then stored at 10 to 15°C for 120 to 150 days. Here, the reason for using the non-heating method of the mixture of purified water and kelp powder is to prevent the fucoidan and laminin, which are active ingredients, from being damaged.

다시마는 한국, 일본, 캄차카반도, 사할린섬 등의 태평양 연안에 서식하는 큰바다말로써 2 ~ 4년생으로써, 요오드·칼륨·칼슘 등 무기염류가 많고 라미닌과 후코이단이 많은 건강식품자원이다.Kelp is a large sea horse that lives on the Pacific coast of Korea, Japan, Kamchatka Peninsula, and Sakhalin Island. It is born in 2 to 4 years, has a lot of inorganic salts such as iodine, potassium, and calcium, and is a health food resource with a lot of laminin and fucoidan.

방사무늬돌김추출물 (Porphyra Yezoensis extract) Radiation pattern Seaweed extract (Porphyra Yezoensis extract)

고압수 또는 고압해수를 이용하여 방사무늬돌김의 이물질을 제거한 후 자연 건조한 다음 분쇄하여 분말을 만든다.Use high-pressure water or high-pressure seawater to remove foreign substances from the radiating pattern, and dry them naturally, then pulverize to make powder.

계속해서, 정제수 100 중량부에 대하여, 방사무늬돌김 분말 30 ~ 35 중량부, 콩비지 분말 10 ~ 15 중량부 및 올리브유 1 ~ 1.5 중량부를 밀폐용기에 충전한 후 90 ~ 130℃에서 5 ~ 7시간 가열한 다음 여과하여 준비한다. 여기서, 올리브유는 소포제이고, 콩비지 분말은 방사무늬돌김의 잔존된 염분을 포집하여 침전시키지 위하여 제공된 천연 침전제이다.Subsequently, with respect to 100 parts by weight of purified water, 30 to 35 parts by weight of radiated pattern powder, 10 to 15 parts by weight of bean curd powder, and 1 to 1.5 parts by weight of olive oil are filled in an airtight container, and then heated at 90 to 130°C for 5 to 7 hours. And then filter to prepare. Here, olive oil is an antifoaming agent, and soybean curd powder is a natural precipitant provided to trap and precipitate the remaining salts of the radioactive pattern protrusions.

방사무늬돌김은 한국, 일본의 해안선을 따라 조간대에서 점심대 상부까지 생육하며 외해에 면한 염분도가 높은 곳에서 잘 생육하는 홍조식물 보라털과의 바닷말로써, 일반 김과 대비할 때 생육기간이 더 길어 소실되는 시기도 늦으며 피부 및 모발의 컨디셔닝을 부여하는 효과가 있다.Radiation-patterned laver grows from the intertidal zone to the upper part of the lunch table along the coastline of Korea and Japan, and is a sea horse of the red algae plant purple hair that grows well in high salinity places facing the open sea. It is also late and has the effect of imparting conditioning to the skin and hair.

갈조추출물(Algae extract) Algae extract

본 실시예의 갈조는 감태, 톳, 다시마을 제외한 미역, 큰실망, 붕어마름, 개다시마, 대황, 모자반을 포함하는 것을 미리 밝혀둔다.Brown algae of this embodiment is revealed in advance that including Ecklonia cava, Tot, seaweed excluding kelp, great disappointment, crucian carp, edamame, rhubarb, and half hatch.

갈조추출물은 갈조를 염화나트륨 용액으로 팽윤시켜 콜로이드상으로 하여 원심분리한 다음 여과하여 준비한다.Brown algae extract is prepared by swelling brown algae with sodium chloride solution, forming a colloid, centrifuging, and filtering.

2. 해초 발효추출물 제조하기2. Manufacture fermented seaweed extract

정제수 100 중량부에 대하여, 건조 세절된 감태 10 ~ 15 중량부, 건조 세절된 톳 5 ~ 7 중량부, 건조 세절된 다시마 5 ~ 10 중량부, 방사무늬돌김 5 ~ 10 중량부 및 세절 건조된 갈조 3 ~ 5 중량부를 혼합한 후 120 ~ 150℃에서 120 ~ 150분 가열한 후 30 ~ 35℃로 냉각한 다음 여과하여 여과액을 제조한다.With respect to 100 parts by weight of purified water, 10 to 15 parts by weight of dried chopped Ecklonia cava, 5 to 7 parts by weight of dried chopped kombu, 5 to 10 parts by weight of dried chopped kelp, 5 to 10 parts by weight of radiated pattern protrusions, and shredded brown algae After mixing 3 to 5 parts by weight, heating at 120 to 150°C for 120 to 150 minutes, cooling to 30 to 35°C, and filtering to prepare a filtrate.

이후, 여과액 100 중량부에 대하여, 설탕 80 ~ 130 중량부 및 자몽씨 추출물 1 ~ 3 중량부를 밀폐용기에 충전한 후 30 ~ 35℃ 온도에서 3 ~ 5개월 발효한 후 여과하여 제조한다.Thereafter, based on 100 parts by weight of the filtrate, 80 to 130 parts by weight of sugar and 1 to 3 parts by weight of grapefruit seed extract are filled in an airtight container, followed by fermentation at a temperature of 30 to 35° C. for 3 to 5 months, followed by filtration.

3. 항균, 항염 씨락토 화장료 조성물 제조하기3. Manufacture of antibacterial and anti-inflammatory sealacto cosmetic composition

(a) 감태추출물, 톳추출물, 다시마추출물, 방사무늬돌김추출물, 갈조추출물, 해초 발효추출물, 유산균 및 올리고당을 준비한다.(a) Prepare the Ecklonia cava extract, hepatitis extract, kelp extract, radish-patterned laver extract, brown algae extract, fermented seaweed extract, lactic acid bacteria and oligosaccharides.

여기서, 본 실시에에 사용되는 유산균은 락토바실러스와 비피도박테리움을 비롯한 프로바이오틱스를 의미하며, 락토바실러스 카제이(L.casei), 락토바실러스 애시도필러스(L.acidophilus), 락토바실러스 불가리쿠스(L.bulgaricus), 비피도박테리움 롱굼(B.longum), 비피도박테리움 비피둠(B.bifidum), 액티레귤라리스(Actiregularis), 락토바실러스 람노서스(L.rhamnosus)이며, 이외에도 다양한 종류의 유산균이 존재할 수 있다.Here, the lactic acid bacteria used in this practice mean probiotics including Lactobacillus and Bifidobacterium, and L. casei, L. acidophilus, and Lactobacillus bulgaricus (L.bulgaricus), Bifidobacterium longum, B.bifidum, Actiregularis, L.rhamnosus, and various other types. Lactobacillus of may be present.

또한, 유산균의 먹이인 올리고당(Oligosaccharides)은 글루코스(glucose), 프룩토스(fructose), 갈락토스(galactose)와 같은 당(糖)이 2∼8개 정도 결합한 당으로 감미를 가진 수용성의 결정성 물질서, 효소 합성에 의해 만들어진 당으로 구성된 물질이며, 탄수화물로부터 유래한 소재로 생리적 기능과 물리화학적 특성이 우수하여 식품에 응용할 수 있는 범위가 넓은 특징이 있다.In addition, oligosaccharides, which are food for lactic acid bacteria, are sugars that contain 2 to 8 sugars such as glucose, fructose, and galactose, and are water-soluble, crystalline substances with sweet taste. , It is a substance composed of sugar made by enzyme synthesis, and it is a material derived from carbohydrates, and has excellent physiological functions and physicochemical properties, and has a wide range of application to food.

(b) 감태추출물 100 중량부에 대하여, 톳추출물 5 ~ 10 중량부, 다시마추출물 20 ~ 35 중량부, 방사무늬돌김추출물 5 ~ 8 중량부, 갈조추출물 5 ~ 10 중량부, 유산균 30 ~ 90 중량부 및 올리고당 3 ~ 25 중량부를 혼합하여 30 ~ 45분간 교반한다.(b) Based on 100 parts by weight of Ecklonia cava extract, 5 to 10 parts by weight of Totilla extract, 20 to 35 parts by weight of kelp extract, 5 to 8 parts by weight of radish-patterned seaweed extract, 5 to 10 parts by weight of brown algae extract, 30 to 90 parts by weight of lactic acid bacteria Parts and 3 to 25 parts by weight of oligosaccharide are mixed and stirred for 30 to 45 minutes.

(c) 그런 다음, 30 ~ 43℃에서 3 ~ 6개월 발효시킨 후 여과하여 초벌 여과물을 제조한다.(c) Then, it is fermented at 30 to 43°C for 3 to 6 months and then filtered to prepare a crude filtrate.

(d) 이후, 초벌 여과물 100 중량부에 대하여 푸코오스 3 ~ 50 중량부를 더 첨가한 후 10 ~ 12시간 교반하여 최종 항균 항염 씨락토 화장료 조성물을 제조한다. 여기서, 푸코오스(Fucose)는 6-디옥시당의 일종으로, D-체, L-체가 각종 당질, 지방질의 비환원말단당으로 6-디옥시갈락토오스, 갈락토메틸로오스, 으로데오스라고도 호칭하는 공지의 당 성분이기 때문에 이에 대한 상세한 설명은 생략하기로 한다.(d) Thereafter, 3 to 50 parts by weight of fucose is further added to 100 parts by weight of the crude filtrate and then stirred for 10 to 12 hours to prepare a final anti-bacterial anti-inflammatory shellacto cosmetic composition. Here, fucose is a kind of 6-deoxysaccharide, and the D- and L-forms are non-reducing end sugars of various sugars and lipids, and are also called 6-deoxygalactose, galactomethylose, and rhodeose. Since it is a known sugar component, a detailed description thereof will be omitted.

또한, 항균 항염 씨락토 화장료 조성물 100 중량부에 대하여 해초 발효추출물 1 ~ 50 중량부를 더 첨가하는 (e)단계를 더 포함할 수 있다. 여기서, 해초 발효추출물은 천연 방부제로 사용된다.In addition, it may further include a step (e) of further adding 1 to 50 parts by weight of seaweed fermented extract based on 100 parts by weight of the anti-bacterial anti-inflammatory sealacto cosmetic composition. Here, the seaweed fermented extract is used as a natural preservative.

4. 항균 항염 씨락토 화장료 조성물의 NO(Nitric Oxide) 생성 억제 평가시험4. Evaluation test for inhibition of NO (Nitric Oxide) production of antibacterial anti-inflammatory sea lacto cosmetic composition

- 실험목적: 항균 항염 씨락토 화장료 조성물의 NO 함량 시험을 실시하여 시료의 항염증 활성을 확인-Purpose of experiment: Confirming the anti-inflammatory activity of the sample by conducting the NO content test of the anti-bacterial anti-inflammatory seed lacto cosmetic composition.

- 실험기관: 충청북도 화장품임상연구지원센터-Laboratory: Chungcheongbuk-do Cosmetics Clinical Research Support Center

- 실험 세포주: Raw246.7-Experimental cell line: Raw246.7

- 실험 사용 장비 및 시약-Laboratory equipment and reagents

Autoclave(코아텍, 대한민국), Dry oven(DAIHAN, 대한민국), Water bath(Polyscience, USA), Incubator(DAIHAN, 대한민국), pH meter(Thermo Orion, USA), Vortex mixer(DAIHAN, 대한민국), Container (Iwaki Pyrex, Japan), Sterile pipette(Eppendorf, 독일), Volumetric flask(KYUNG IN, 대한민국), Mechanical shaker(Jisico, 대한민국), Clean bench(CHC, 대한민국), DMSO(Sigma, USA), DMEM high glucose(Biowest, USA), Fetal Bovine Serum(Biowest, USA), Antibiotics(Gibco, USA), MTT(Invitrogen, USA), LPS(Sima, USA), NO 진단 kit(Griess Reagent System, USA)Autoclave(Coretech, Korea), Dry oven(DAIHAN, Korea), Water bath(Polyscience, USA), Incubator(DAIHAN, Korea), pH meter(Thermo Orion, USA), Vortex mixer(DAIHAN, Korea), Container ( Iwaki Pyrex, Japan), Sterile pipette (Eppendorf, Germany), Volumetric flask (KYUNG IN, Korea), Mechanical shaker (Jisico, Korea), Clean bench (CHC, Korea), DMSO (Sigma, USA), DMEM high glucose ( Biowest, USA), Fetal Bovine Serum (Biowest, USA), Antibiotics (Gibco, USA), MTT (Invitrogen, USA), LPS (Sima, USA), NO diagnostic kit (Griess Reagent System, USA)

실험방법Experiment method

㉮ 군 구성은 하기 표 1과 같다.The group configuration is shown in Table 1 below.

Figure pat00001
Figure pat00001

㉯ 세포 분주㉯ cell dispensing

96 well plate에 세포를 2 × 105 cell/well 농도로 분주하고, 37℃, 5% CO2 배양기에서 24시간 배양하였다. The cells were dispensed in a 96 well plate at a concentration of 2 × 10 5 cells/well, and cultured for 24 hours in a 37°C, 5% CO 2 incubator.

㉰ 시험물질처리㉰ Test substance treatment

LPS를 첨가한 배지로 시험물질을 농도별로 희석 된 배지로 교체하여 37℃, 5% CO2 배양기에서 24시간 배양하였다.With the medium to which LPS was added, the test substance was replaced with a medium diluted by concentration, and cultured in a 37°C, 5% CO 2 incubator for 24 hours.

㉱ NO 생성 억제량 측정㉱ Measurement of NO generation inhibition

세포배양액 50 ㎍/mL와 Griess 시약 50 ㎍/mL을 혼합하여 암소에 방치 후 520 nm 파장에서 흡광도를 측정하였다.50 µg/mL of cell culture solution and 50 µg/mL of Griess reagent were mixed and left in the dark, and the absorbance was measured at a wavelength of 520 nm.

㉲ 결과처리㉲ result processing

NO 생성량은 Nitric Oxide standard solution로 농도별 표준곡선을 작성하여 배양액 내의 NO 함량을 산출하였다. As for the amount of NO produced, the NO content in the culture medium was calculated by preparing a standard curve for each concentration using the Nitric Oxide standard solution.

실험 결과Experiment result

씨락토컴플렉스를 원액으로 하여 20배 희석 농도로 처리하였더니 LPS 처리군 대비 47.79%의 NO 생성 억제률이 관찰되었다.When treated with a 20-fold dilution concentration using C. lacto complex as a stock solution, a 47.79% inhibition rate of NO production was observed compared to the LPS treatment group.

결과적으로, 본 시험은 씨락토컴플렉스 시료에 대한 항염증 활성을 평가하기 위하여 NO(Nitric Oxide) 생성 억제 효과를 측정하였다. 세포독성 결과를 바탕으로 씨락토컴플렉스 시료를 원액으로 20배 희석 농도로 처리하였더니 LPS 처리군 대비 47.79%의 NO 생성억제률이 관찰되었는 바, 20배 희석 농도에서 NO 생성 억제 효과를 보이는 것을 확인하였다.As a result, in this test, the inhibitory effect of NO (Nitric Oxide) production was measured in order to evaluate the anti-inflammatory activity of the C-lactocomplex sample. Based on the cytotoxicity results, when the C-lactocomplex sample was treated with a stock solution at a 20-fold dilution concentration, a 47.79% inhibition rate of NO production was observed compared to the LPS-treated group, confirming that the 20-fold dilution concentration showed an inhibitory effect on NO production. I did.

이와 같은 본 발명은 일 실시예에 한정되어 설명되었으나, 이에 한정되지 않고 본 발명의 기술적 사상을 토대로 변형되는 실시예들은 모두 본 발명의 권리범위에 속함이 분명하다.The present invention has been described by being limited to one embodiment, but the embodiments are not limited thereto, and all embodiments modified based on the technical idea of the present invention belong to the scope of the present invention.

Claims (5)

(a) 가공된 감태추출물, 톳추출물, 다시마추출물, 방사무늬돌김추출물, 갈조추출물, 유산균 및 올리고당을 준비하는 단계와;
(b) 감태추출물 100 중량부에 대하여, 톳추출물 5 ~ 10 중량부, 다시마추출물 20 ~ 35 중량부, 방사무늬돌김추출물 5 ~ 8 중량부, 갈조추출물 5 ~ 10 중량부, 유산균 30 ~ 90 중량부 및 올리고당 3 ~ 25 중량부를 혼합하여 30 ~ 45분간 교반하는 단계와;
(c) 30 ~ 43℃에서 3 ~ 6개월 발효시킨 후 여과하여 초벌 여과물을 제조하는 단계와;
(d) 상기 초벌 여과물 100 중량부에 대하여 푸코오스 3 ~ 50 중량부를 더 첨가한 후 10 ~ 12시간 교반하여 항균 항염 씨락토 화장료 조성물을 제조하는 단계로 이루어진 항균 항염 씨락토 화장료 조성물의 제조방법.
(a) preparing the processed Ecklonia cava extract, hepatitis extract, kelp extract, radiated pebbles extract, brown algae extract, lactic acid bacteria and oligosaccharides;
(b) Based on 100 parts by weight of Ecklonia cava extract, 5 to 10 parts by weight of Toot extract, 20 to 35 parts by weight of kelp extract, 5 to 8 parts by weight of radish-patterned seaweed extract, 5 to 10 parts by weight of brown algae extract, 30 to 90 parts by weight of lactic acid bacteria Mixing parts and 3 to 25 parts by weight of oligosaccharide and stirring for 30 to 45 minutes;
(c) fermenting at 30 to 43° C. for 3 to 6 months and then filtering to prepare a crude filtrate;
(d) a method for preparing an anti-bacterial anti-inflammatory shellacto cosmetic composition comprising the step of preparing an anti-bacterial anti-inflammatory shellacto cosmetic composition by adding 3 to 50 parts by weight of fucose to 100 parts by weight of the crude filtrate and then stirring for 10 to 12 hours .
제 1 항에 있어서,
상기 (a)단계의 감태추출물은, 정제수 100 중량부에 대하여, 건조된 감태 30 ~ 45 중량부 및 산초씨유 0.1 ~ 0.3 중량부를 밀폐용기에 충전한 후 90 ~ 130℃에서 12 ~ 15시간 가열한 다음 여과하여 제조되고,
상기 (a)단계의 톳추출물은, 정제수 100 중량부에 대하여, 톳 분말 50 ~ 55 중량부, 자몽씨 추출물 0.1 ~ 0.1 중량부 및 올리브유 1 ~ 1.5 중량부를 밀폐용기에 충전한 후 90 ~ 130℃에서 12 ~ 15시간 가열한 다음 여과하여 제조되고,
상기 (a)단계의 다시마추출물은, (가) 건조된 다시마를 정제수에 5 ~ 10일간 침지한 후 10 ~ 15℃에서 재건조하는 단계와; (나) 재건조된 다시마를 자숙한 후 건조하는 공정을 1 ~ 5회 반복하는 단계와; (다) 자숙건조된 다시마를 분쇄하여 분말로 만드는 단계와; 정제수 100 중량부에 대하여, 다시마 분말 5 ~ 15 중량부를 혼합한 후 회전수 100 ~ 150rpm으로 30 ~ 35일간 교반한 후 여과한 다음 10 ~ 15℃에서 120 ~ 150일간 저장하여 제조되는 단계로 이루어지고,
상기 (a)단계의 방사무늬돌김추출물은, 정제수 100 중량부에 대하여, 방사무늬돌김 분말 30 ~ 35 중량부, 콩비지 분말 10 ~ 15 중량부 및 올리브유 1 ~ 1.5 중량부를 밀폐용기에 충전한 후 90 ~ 130℃에서 5 ~ 7시간 가열한 다음 여과하여 제조되는 것을 특징으로 하는 항균 항염 씨락토 화장료 조성물의 제조방법.
The method of claim 1,
The Ecklonia cava extract of step (a) is heated at 90 to 130°C for 12 to 15 hours after filling 30 to 45 parts by weight of dried Ecklonia and 0.1 to 0.3 parts by weight of Sancho Seed oil in an airtight container based on 100 parts by weight of purified water. And then filtered to prepare,
In the above step (a), based on 100 parts by weight of purified water, 50 to 55 parts by weight of Hemischia powder, 0.1 to 0.1 parts by weight of grapefruit seed extract, and 1 to 1.5 parts by weight of olive oil are filled into an airtight container, and then 90 to 130°C. It is prepared by heating at 12 to 15 hours and then filtering,
The kelp extract of step (a) includes the steps of: (a) immersing the dried kelp in purified water for 5 to 10 days and then redrying at 10 to 15°C; (B) repeating the process of drying the re-dried kelp after self-cooking 1 to 5 times; (C) pulverizing the self-dried kelp to form a powder; With respect to 100 parts by weight of purified water, 5 to 15 parts by weight of kelp powder is mixed, stirred at a rotational speed of 100 to 150 rpm for 30 to 35 days, filtered, and then stored at 10 to 15°C for 120 to 150 days. ,
The radiated pattern protrusion extract of step (a) is charged in an airtight container with 30 to 35 parts by weight of radiant pattern protrusion powder, 10 to 15 parts by weight of bean curd powder, and 1 to 1.5 parts by weight of olive oil based on 100 parts by weight of purified water. Method for producing an anti-bacterial anti-inflammatory sea lacto cosmetic composition, characterized in that prepared by heating at ~ 130 ℃ for 5 to 7 hours and then filtered.
제 1 항에 있어서,
상기 (d)단계 이후에 상기 항균 항염 씨락토 화장료 조성물 100 중량부에 대하여 해초 발효추출물 1 ~ 50 중량부를 더 첨가하는 (e)단계를 더 포함하되,
상기 해초 발효추출물은, (ㄱ) 정제수 100 중량부에 대하여, 건조 세절된 감태 10 ~ 15 중량부, 건조 세절된 톳 5 ~ 7 중량부, 건조 세절된 다시마 5 ~ 10 중량부, 방사무늬돌김 5 ~ 10 중량부 및 세절 건조된 갈조 3 ~ 5 중량부를 혼합한 후 120 ~ 150℃에서 120 ~ 150분 가열한 후 30 ~ 35℃로 냉각한 다음 여과하여 여과액을 제조하는 단계와; (ㄴ) 상기 여과액 100 중량부에 대하여, 설탕 80 ~ 130 중량부 및 자몽씨 추출물 1 ~ 3 중량부를 밀폐용기에 충전한 후 30 ~ 35℃ 온도에서 3 ~ 5개월 발효한 후 여과하여 제조되는 단계로 이루어지는 것을 특징으로 하는 항균 항염 씨락토 화장료 조성물의 제조방법.
The method of claim 1,
After the step (d), further comprising a step (e) of further adding 1 to 50 parts by weight of seaweed fermented extract with respect to 100 parts by weight of the antibacterial anti-inflammatory sea lacto cosmetic composition,
The fermented seaweed extract is, (a) 10 to 15 parts by weight of dried chopped Ecklonia cava, 5 to 7 parts by weight of dried chopped kombu, 5 to 10 parts by weight of dried chopped kelp, and 5 Mixing ~ 10 parts by weight and 3 to 5 parts by weight of finely dried brown algae, heating at 120 to 150°C for 120 to 150 minutes, cooling to 30 to 35°C, and filtering to prepare a filtrate; (B) Based on 100 parts by weight of the filtrate, 80 to 130 parts by weight of sugar and 1 to 3 parts by weight of grapefruit seed extract are filled in an airtight container, fermented at 30 to 35°C for 3 to 5 months, and then filtered. Method for producing an antibacterial anti-inflammatory sea lacto cosmetic composition, characterized in that consisting of steps.
제 1 항에 있어서,
상기 유산균은 락토바실러스 카제이, 락토바실러스 애시도필러스, 락토바실러스 불가리쿠스, 비피도박테리움 롱굼, 비피도박테리움 비피둠, 액티레귤라리스 또는 락토바실러스 람노서스 중 어느 하나 이상인 것을 특징으로 하는 항균 항염 씨락토 화장료 조성물의 제조방법.
The method of claim 1,
The lactic acid bacteria are antibacterial, characterized in that at least one of Lactobacillus casei, Lactobacillus acidophilus, Lactobacillus bulgaricus, Bifidobacterium longum, Bifidobacterium bifidum, Actiregularis or Lactobacillus rhamnosus Method for producing an anti-inflammatory sea lacto cosmetic composition.
청구항 1 내지 청구항 4의 어느 한 방법에 의해 제조된 항균 항염 씨락토 화장료 조성물.Antibacterial anti-inflammatory sea lacto cosmetic composition prepared by any one of claims 1 to 4.
KR1020190119202A 2019-09-26 2019-09-26 Cosmetic composition with sea Lacto for antibacterial and antiinflammatory and manufacturing method thereof KR20210036767A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020190119202A KR20210036767A (en) 2019-09-26 2019-09-26 Cosmetic composition with sea Lacto for antibacterial and antiinflammatory and manufacturing method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020190119202A KR20210036767A (en) 2019-09-26 2019-09-26 Cosmetic composition with sea Lacto for antibacterial and antiinflammatory and manufacturing method thereof

Publications (1)

Publication Number Publication Date
KR20210036767A true KR20210036767A (en) 2021-04-05

Family

ID=75462184

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020190119202A KR20210036767A (en) 2019-09-26 2019-09-26 Cosmetic composition with sea Lacto for antibacterial and antiinflammatory and manufacturing method thereof

Country Status (1)

Country Link
KR (1) KR20210036767A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114748380A (en) * 2022-05-11 2022-07-15 江苏科技大学 Composition containing marine plant extract and application thereof

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114748380A (en) * 2022-05-11 2022-07-15 江苏科技大学 Composition containing marine plant extract and application thereof
CN114748380B (en) * 2022-05-11 2023-07-25 江苏科技大学 Composition containing marine plant extract and application thereof

Similar Documents

Publication Publication Date Title
CN101212952B (en) Agent for external application to the skin
US20080226740A1 (en) Marine algal extracts comprising marine algal polysaccharides of low degree polymerizaton, and the preparation processes and uses thereof
KR101814100B1 (en) Soap composition comprising red ginseng for improving atopic dermatitis and preparation method thereof
JP7315985B2 (en) Soap composition using mountain ginseng and soap containing the same
CN102630776A (en) Ginkgo leaf extracting technology and ginkgo black tea processing method
CN108815031B (en) Traditional Chinese medicine composition fermented raw pulp with function of balancing skin micro-ecology and preparation method and application thereof
CN108096146A (en) With whitening and anti-aging, the rose enzyme of anti-inflammatory effect and its application in cosmetics
CN110256598A (en) A kind of preparation method of difference bioactivity lentinan
CN108042456A (en) A kind of preparation method and application of dendrobium candidum fermentate
CN113143817B (en) Jerusalem artichoke acne-removing composition and application thereof
KR20210036767A (en) Cosmetic composition with sea Lacto for antibacterial and antiinflammatory and manufacturing method thereof
CN112137919B (en) Application of dictyophora indusiata egg extract in preparation of external beauty and skin care products and external beauty and skin care products based on same
JP6475475B2 (en) Collagen production promoter
KR102165525B1 (en) Composition for improving acne skin
KR101794419B1 (en) Osmotic enzyme fermentation natural liposome containing mushroom, process for the preparation thereof, and cosmetic, food or pharmaceutical composition comprising the same
KR102666911B1 (en) Method for manufacturing fermented complex extract with anti-aging and whitening activity
KR101851742B1 (en) Cosmetic composition containing porifera spicule coated with sawhangsan and method for manufacturing the same
CN108619017A (en) A kind of Tianshan Mountains snow chrysanthemum skin care compositions and its application
KR101143363B1 (en) The preparing method of Centella asiatica nanoparticle using chitosan, the product, and the food containing the product
CN102000016B (en) Dispersing powder compound extract, preparation method and application thereof
CN109566806A (en) It is a kind of for promoting the sargassum fusifome extracting solution of selenium-enriched vine tea health-care effect
KR100302505B1 (en) Fermented product using lactic acid bacteria and cosmetic composition
KR101467162B1 (en) Essential Composition with Carboxy Generating Substance for Improving Blood Flow and Treating Acne and Method for Producing the Same
KR20220112525A (en) Method of manufacturing cosmetic composition for improving skim elasticiy comprising filtrate of aged slime by vinegar and cosmetic composition for improving skim elasticiy manufactured by using the same
KR20180057906A (en) Earthworm fermented extracts and method for manuracturing thereof and natural cosmetics and functional health food comprising same

Legal Events

Date Code Title Description
E902 Notification of reason for refusal
E601 Decision to refuse application